Celaid Therapeutics is pleased to announce that its presentation has been selected as a candidate for the Best Presentation Award at the 74th Annual Meeting of the Japan Society of Transfusion Medicine and Cell Therapy, to be held from May 14 (Thu) to May 16 (Sat), 2026.
This annual meeting is one of Japan’s leading academic conferences in the fields of transfusion medicine and cell therapy. Following a rigorous pre-review process, our submitted abstract has been selected as a candidate for the Best Presentation Award.
We will present our hematopoietic stem cell expansion technology and its prospects for clinical application according to the schedule below. We look forward to your participation.
<Conference Overview>
Meeting Name: The 74th Annual Meeting of the Japan Society of Transfusion Medicine and Cell Therapy
Dates: May 14 (Thu) – May 16 (Sat), 2026
Venue: PACIFICO Yokohama North, 3F–4F
Congress President: Hitoshi Okazaki (Department of Transfusion Medicine, The University of Tokyo Hospital)
<Celaid Therapeutics Presentation>
Date & Time: May 14 (Thu), 14:20–17:30
Venue: Main Hall (Room 1)
Presentation Title:
SO-01: Hematopoietic Stem Cell Expansion Technology Using a Novel Epigenetic Modulator and Its Prospects for Clinical Application
